Explore the cutting-edge world of CAR-T therapies for T cell malignancies in this keynote presentation from the 2023 Cancer Genomics Consortium Annual Meeting. Delivered by John DiPersio and introduced by Obi Griffith, this 51-minute talk delves into the latest advancements in cancer treatment. Gain insights into how chimeric antigen receptor T-cell therapy is revolutionizing the approach to T cell malignancies. Learn about the Cancer Genomics Consortium's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic diagnoses for all cancer patients. Discover how this organization strives to be the authoritative voice in clinical cancer genomic testing guidance.
Overview
Syllabus
CGC 2023 Keynote Presentation - CAR-T Therapies for T cell Malignancies
Taught by
Cancer Genomics Consortium
Related Courses
-
Memory-Rich CAR T Cell Engineering by PiggyBac Transposon System for Solid Malignancies
-
Identification of Tumor-Reactive T Cell Receptors Through Functional Single Cell Interaction Analysis for Personalized T Cell Therapy
-
Monitoring of Circulating CAR T Cells
-
Heterogeneity of Breast Cancer Genomes: Going Beyond Therapy to Risk Assessment and Prevention
-
CAR T-Cell Therapy for Pediatric Cancer - Satiro de Oliveira, MD - UCLAMDChat
-
Multivalent RNA CAR-T Cell for Malignant Glioma
